Patents, Defense, and Startups: What Dual-Use Startups Need to Know About Patents in 2026

Why It Matters

The policy changes reduce entry costs, deliver critical funding, and redefine patent risk, turning defense‑adjacent markets into a scalable growth channel for emerging technology companies.

Key Takeaways

• DoD patent holiday offers free CELs for hundreds of military patents.
• Applications for CELs must be submitted by July 22, 2026.
• Section 1498 forces patent suits against the government, not contractors.
• SBIR/STTR programs deliver $4 billion yearly, retaining startup IP ownership.
• Re‑authorized SBIR/STTR legislation (S. 3971) awaits presidential sign‑off.

Pulse Analysis

The DoD’s patent holiday reflects a broader shift toward open innovation in national security. By making a curated portfolio of military‑origin patents available under no‑fee Commercial Evaluation Licenses, the government lowers the R&D cost curve for early‑stage firms. Startups can experiment with AI, autonomy, communications and advanced materials without upfront royalty burdens, accelerating proof‑of‑concept cycles and positioning themselves for later commercial licensing or direct contracts. The July 22 deadline creates a short window that incentivizes rapid internal assessments and partnership outreach.

Section 1498 adds a nuanced layer to patent strategy for defense‑related ventures. When a patented invention is used with government authorization, the patent holder’s remedy shifts to the Court of Federal Claims, stripping contractors of traditional injunctive leverage. For startups, this means that while direct litigation against a prime contractor is unlikely, the government itself becomes the defendant, often resulting in monetary damages rather than market‑blocking orders. Understanding this dynamic is essential for valuation models, as investors weigh the protective value of patents against the reduced enforcement toolkit in government contracts.

SBIR and STTR remain the most reliable pipelines for non‑dilutive capital in the dual‑use space. With cumulative funding exceeding $70 billion since inception and annual awards topping $4 billion, these programs enable startups to de‑risk technology development while retaining IP ownership. The pending re‑authorization under S. 3971 promises continuity and potentially higher set‑aside percentages, reinforcing the government’s commitment to small‑business innovation. Companies that align their commercial roadmap with SBIR/STTR milestones can leverage government validation to attract private investors, negotiate better terms with defense primes, and ultimately scale their technologies across both military and civilian markets.